Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 4Q Financials: AMRI | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

4Q Financials: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

4Q Revenue: $39.1 million (-15%)

4Q Loss: $942 thousand (earnings were $3.4 million 4Q2004)

FY Revenue: $183.9 million (+8%)

FY Earnings: $16.3 million (loss of $11.7 million FY2004)

Comments: Contract revenue from discovery services in the quarter was $8.3 million, up 18%. Contract revenue from development and small scale manufacturing services in the quarter was $7.5 million, up 19%. Contract revenue from large scale manufacturing in the quarter was $17.1 million, down 17%. Recurring royalties from Allegra in the quarter were $6.2 million, down 49%.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters